Radiation treatment for Ewing family of tumors in adults: the University of Florida experience

Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):1140-5. doi: 10.1016/j.ijrobp.2008.02.071. Epub 2008 May 29.

Abstract

Purpose: To review the clinical characteristics and outcomes of adult patients with Ewing family of tumors treated with radiation at the University of Florida.

Methods and materials: Clinical features, treatment, and outcomes of 47 patients older than 18 years with Ewing family of tumors treated with combined radiation therapy and chemotherapy from 1970 to 2005 were retrospectively reviewed. Analysis was stratified by age older or younger than 30 years. Patients with metastatic disease at the time of diagnosis were excluded from the study.

Results: The 29 men and 18 women had a median age of 24 years. Thirty-three patients were 18-30 years old and 14 patients were older than 30 years. Median follow-up of living patients was 8.2 years. The 5-year overall survival rate for all patients was 43% (p = 0.8523). The 5-year local control rate for all patients was 75% (p = 0.9326). The 5-year rate of freedom from distant metastasis for all patients was 45% (p = 0.5471). There were no significant differences in 5-year overall survival, local control, and freedom from distant metastasis rates; patterns of distant failure; or toxicity profiles between older adult patients and younger adult patients.

Conclusions: We found that the natural history and treatment outcomes of the Ewing family of tumors were consistently similar in adults (young and old) and children. Thus, aggressive combined modality approaches should be considered for adult patients.

MeSH terms

  • Academic Medical Centers
  • Adolescent
  • Adult
  • Age Factors
  • Bone Neoplasms / radiotherapy*
  • Child
  • Female
  • Florida
  • Humans
  • Male
  • Retrospective Studies
  • Sarcoma, Ewing / radiotherapy*
  • Treatment Outcome